|
The latest news on scientific milestones, capital sources and venture financings, corporate financial and stock performance, strategic alliances, agreements, sales and mergers, and FDA and congressional actions. Or Search for these keywords and see what you find!
Go to This Week's BioWorld International and read about:
News on international strategic deals, worldwide investment opportunities, country-by-country regulatory issues and product development. Or do a Search and find out just how much international news we cover!
Go to This Week's BioWorld Financial Watch to look up:
Collaborations, public and private financings, clinical trials and FDA submissions, stock market activity, and underwriter and venture capital portfolio performances. Or Search our extensive news archive for the financial information that's important to you!
Go to the 2004, 2003, 2002, 2001, 2000, 1999 or 1998 BioWorld Biotechnology State of the Industry Report and read about:
New product development, biotech stock performance, corporate deals, scientific breakthroughs. Or do a Search to find information on IPOs, research and financial collaborations as well as a wealth of feature stories on the year(s) in review.
Go to BioScan to conduct a Search for profiles on more than 1,800 companies in our database. Details include:
Inside information on strategic alliances, mergers, product acquisitions, new products in development, licensing and R&D agreements, principal investors, financial information, and key personnel.
Browse the BioWorld 2003 Genomics Review to learn about:
A detailed profile of the genomics industry from its formative years to its explosive present. Learn about the companies pioneering gene-based drug development and find out about the latest technology in gene discovery and functional genomics.
Go to the BioWorld Executive Compensation Report to check out profiles on more than 231 companies with specific detail paid to:
The presidents and CEOs and VPs of finance and research: what they're being paid, who they're teaming up with, how long they've been in charge, and how dominant they are.
Search the BioWorld Phase III Report to track the progress of biotech products in advanced clinical trials.The data are broken down by:
Company name and product name, type, indication and status. Plus, each product is conveniently categorized by treatment area: cancer, central nervous system, circulatory, diabetes, infectious diseases, and miscellaneous.
IPOs, Public Offerings, Private Offerings, Mergers & Acquisitions, Biotech/Pharma Collaborations, Biotech/Biotech Collaborations, Products on the Market, and Biotech Market Capitalization.
|
